Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Georges Gemayel

Director at Supernus Pharmaceuticals, Inc. (SUPN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.0M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 9SEC SUPNSupernus Pharmaceuticals, Inc. Sell 10,00028,159 held (−26%) $53.71 $537K -29.5%
Mar 9SEC SUPNSupernus Pharmaceuticals, Inc. Sell 8,78727,277 held (−24%) $53.00 $466K -28.5%
  • Sell

    Director Georges Gemayel sold $537K of SUPN at $53.71 — cuts the stake by 26%.